
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Croat Med J</journal-id><journal-id journal-id-type="iso-abbrev">Croat Med J</journal-id><journal-id journal-id-type="publisher-id">CMJ</journal-id><journal-title-group><journal-title>Croatian Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">0353-9504</issn><issn pub-type="epub">1332-8166</issn><publisher><publisher-name>Croatian Medical Schools</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">33150759</article-id><article-id pub-id-type="pmc">7684532</article-id><article-id pub-id-type="publisher-id">CroatMedJ_61_0410</article-id><article-id pub-id-type="doi">10.3325/cmj.2020.61.410</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Microsurgical versus endoscopic surgery for non-functioning pituitary adenomas: a retrospective study</article-title><alt-title alt-title-type="running-head">&#x0010c;es&#x000e1;k et al: Microsurgical versus endoscopic surgery for non-functioning pituitary adenomas</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>&#x0010c;es&#x000e1;k</surname><given-names>Tom&#x000e1;&#x00161;</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>P&#x000f3;czo&#x00161;</surname><given-names>Pavel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Adamkov</surname><given-names>Jaroslav</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>&#x0010c;elakovsk&#x000fd;</surname><given-names>Petr</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gabalec</surname><given-names>Filip</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Soukup</surname><given-names>Ji&#x00159;&#x000ed;</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dvo&#x00159;&#x000e1;kov&#x000e1;</surname><given-names>Radka</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kr&#x0016f;pa</surname><given-names>Petr</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Neurosurgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic</aff><aff id="aff2"><label>2</label>Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic</aff><aff id="aff3"><label>3</label>4th Department of Internal Medicine, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic</aff><aff id="aff4"><label>4</label>The Fingerland Department of Pathology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic</aff><aff id="aff5"><label>5</label>Department of Radiology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to:&#x02028;Tom&#x000e1;&#x00161; &#x0010c;es&#x000e1;k&#x02028;Department of Neurosurgery&#x02028;University Hospital Hradec Kralove&#x02028;Sokolsk&#x000e1; 581&#x02028;500 05 Hradec Kr&#x000e1;lov&#x000e9;, Czech Republic&#x02028;<email xlink:href="tomas.cesak@fnhk.cz">tomas.cesak@fnhk.cz</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2020</year></pub-date><volume>61</volume><issue>5</issue><fpage>410</fpage><lpage>421</lpage><history><date date-type="received"><day>25</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>05</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 by the Croatian Medical Journal. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Aim</title><p>To compare microsurgical technique (mTSS) and endoscopic technique (eTSS) in the treatment of non-functioning pituitary adenomas (NFPAs).</p></sec><sec><title>Methods</title><p>We retrospectively evaluated the charts of 50 patients who underwent either mTSS or eTSS for NFPA in the Department of Neurosurgery, University Hospital Hradec Kralove from 2013 to 2019. We enrolled all patients who were not treated by postoperative adjuvant radiotherapy and who underwent at least two regular postoperative magnetic resonance imaging (MRI) tests. We compared the groups in terms of the extent of resection, surgery duration, blood loss, complication rate, overall clinical effect on the endocrinological and ophthalmological deficit, and postoperative growth pattern of the residual tumor mass.</p></sec><sec><title>Results</title><p>The mTSS group had significantly shorter surgical time (75 min vs 127 min, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and lower perioperative blood loss (156 mL vs 256 mL, <italic>P</italic>&#x02009;=&#x02009;0.027). The groups did not significantly differ in the extent of resection, overall clinical or hormonal effect, and the complication rate. The extent of resection did not correlate with tumor consistency, while the tumor growth rate did not correlate with age or Ki-67 expression.</p></sec><sec><title>Conclusions</title><p>There was no major difference between the approaches in surgery radicality or safeness. However, eTSS remains the method of choice due to its potentially higher postoperative preservation of hormonal functions.</p></sec></abstract></article-meta></front><body><p>Pituitary adenomas are benign tumors representing around 10%-15% of all intracranial tumors, with a peak incidence in the third or fourth decade of life and no sex predominance. They are the third most common intracranial neoplasm in the elderly (<xref rid="R1" ref-type="bibr">1</xref>-<xref rid="R3" ref-type="bibr">3</xref>). Non-functioning pituitary adenomas (NFPAs) comprise 25%-40% of all pituitary neoplasms and are characterized by the absence of clinically measured hypersecretion of hypophyseal hormones (<xref rid="R4" ref-type="bibr">4</xref>-<xref rid="R6" ref-type="bibr">6</xref>). The annual incidence of NFPAs is 0.65-2.34/100&#x02009;000 patients, with a prevalence of 7-41/100&#x02009;000 cases (<xref rid="R7" ref-type="bibr">7</xref>-<xref rid="R9" ref-type="bibr">9</xref>).</p><p>Treatment options for patients with NFPAs include careful surveillance with watchful waiting, radiotherapy, or surgery. Surgical treatment, as a first-line therapy, is performed in patients with larger tumors and signs and symptoms arising from compression. The most frequently used surgical approach is transsphenoidal surgery (TSS). Microscopic transnasal surgical technique (mTSS) has for many years been the gold standard in the treatment of pathologies in the sellar region (<xref rid="R10" ref-type="bibr">10</xref>-<xref rid="R13" ref-type="bibr">13</xref>). Endoscopic transnasal approach (eTSS) was introduced in the early 1990s and has quickly developed in the last decade, mainly due to improved quality of visualization (<xref rid="R14" ref-type="bibr">14</xref>-<xref rid="R21" ref-type="bibr">21</xref>). Despite a lack of high-quality comparison of the efficacies of the two approaches, endoscopic surgery was adopted in a vast majority of neurosurgical centers, including ours. However, the overall advantages and disadvantages of both techniques are still a matter of debate, as most of studies yielded controversial conclusions resulting from various research methods.</p><p>The aim of our study was to compare the two surgical methods for the treatment of NFPAs. We evaluated the extent of resection, safety, surgery duration, blood loss, and the overall clinical effect on endocrinological and ophthalmological deficit. We also analyzed how surgical radicality depended on the consistency/invasiveness of the tumor mass and assessed the correlation of the postoperative growth pattern of the residual tumor mass with age and Ki-67 index.</p><sec sec-type="methods"><title>Patients and methods</title><p>We retrospectively reviewed the charts of 50 patients who had undergone either mTSS or eTSS for NFPA (Hardy 0-IV, Knosp 0-3) without adjuvant radiotherapy in the Department of Neurosurgery, University Hospital Hradec Kralove between January 2013 and January 2019. Each group comprised of 25 patients. Endoscopic technique was chosen for patients with more extrasellar tumor propagation and was preferred mainly in the past three years. All the operations were performed by the first author, who is versed in both techniques. mTSS was performed by two neurosurgeons, and eTSS by two neurosurgeons assisted by an otorhinolaryngology surgeon, who performed the endoscopic fenestration of the sphenoidal sinus. All patients were followed-up for a minimum of 12 months. The follow up visits were scheduled at 3 and 12 months post-operatively and involved magnetic resonance imaging (MRI) and endocrinological and ophthalmological examination. According to preoperative MRI, adenomas were classified according to standard classification systems (<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R22" ref-type="bibr">22</xref>). During the operation, tumor consistency (soft, stiff, mixed), surgical time, and blood loss were assessed. The extent of the resection was evaluated by postoperative coronal MRI T1 images using graphics software (Brainlab, Munich, Germany) and graded as gross total resection (GTR, no macroscopic residuum), near-total resection (NTR, &#x02265;95% of the preoperatively visualized mass), and sub-total resection (STR, &#x0003c;95% of the preoperatively visualized mass). During the follow-up, postoperative surgical complications were noted, with special attention to sinusitis and its symptoms (odor, secretion) and signs (thickening and filling of the sphenoidal cavity), episodes of bleeding or liquorrhea, vision disorders, and meningitis. Tumor volume doubling time (TVDT) was calculated according to Tanaka et al (<xref rid="R23" ref-type="bibr">23</xref>). Complete immunohistological examination of the tumorous specimen was performed with quantification of Ki-67 in the tumorous hot spots.</p><sec><title>Statistical analysis</title><p>The normality of distribution was tested with the Anderson-Darling test. The data are expressed as the mean&#x02009;&#x000b1;&#x02009;standard deviations or medians with minimums and maximums. The significance of differences between the groups was assessed with either the <italic>t</italic> test or Wilcoxon test. For pair to pair subgroup testing (consistency/size/radicality), the Pearson and Spearman correlation test and Fisher exact test were used. The level of statistical significance was set at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05. The analysis was conducted with R (R Development Core Team, 2018).</p></sec></sec><sec sec-type="results"><title>Results</title><p>Patients from the two groups did not differ in age or sex. The eTSS group had significantly shorter postoperative follow-up because the method was introduced only in the last three years of the study (<xref rid="T1" ref-type="table">Table 1</xref>). The initial volume of NFPAs was slightly higher in the eTSS group, but the difference was not significant (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The most frequent NFPA types in the mTSS group were Hardy II-A and Knosp 2, while the most frequent types in the eTSS group were Hardy II-B and Knosp 3 grades (<xref ref-type="fig" rid="F1">Figure 1B</xref>, <xref ref-type="fig" rid="F1">Figure 1C</xref>). These results indicate that the eTSS group had more parasellar and suprasellar tumor propagation, which is more challenging for the surgeon. According to the histopathological diagnosis, the most common NFPA type was gonadotropic adenoma (<xref ref-type="fig" rid="F1">Figure 1D</xref>).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic data of patients with non-functioning pituitary adenomas who underwent endoscopic (eTSS) or microsurgical transsphenoidal surgery (mTSS)</p></caption><table frame="hsides" rules="groups"><col width="117" span="1"/><col width="48" span="1"/><col width="48" span="1"/><col width="44" span="1"/><thead><tr><th valign="bottom" align="left" scope="col" rowspan="1" colspan="1"/><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">eTSS</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">mTSS</th><th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td valign="bottom" align="left" scope="row" rowspan="1" colspan="1"><bold>Sex (M:W)</bold><hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">16:9<hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">16:9<hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">1*<hr/></td></tr><tr><td valign="bottom" align="left" scope="row" rowspan="1" colspan="1"><bold>Age (years)</bold><hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">58.7<hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">59.6<hr/></td><td valign="bottom" align="center" rowspan="1" colspan="1">0.8<sup>&#x02020;</sup><hr/></td></tr><tr><td valign="bottom" align="left" scope="row" rowspan="1" colspan="1"><bold>Follow-up (months)</bold></td><td valign="bottom" align="center" rowspan="1" colspan="1">23.6</td><td valign="bottom" align="center" rowspan="1" colspan="1">39</td><td valign="bottom" align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup>&#x02021;</sup></td></tr></tbody></table><table-wrap-foot><p>*Fisher Exact Test.</p><p>&#x02020;t test.</p><p>&#x02021;Wilcoxon test.</p></table-wrap-foot></table-wrap><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Characterization of non-functioning pituitary adenomas (NFPAs) indicated for surgery. Despite slightly higher initial volume of NFPAs in the endoscopic transsphenoidal surgery (eTSS) group, no significant difference was observed (<bold>A</bold>). The types of NFPAs operated in both groups according to Hardy&#x02019;s classification (<bold>B</bold>) and Knosp&#x000b4;s classification (<bold>C</bold>). Histopathological diagnosis showed that the majority were gonadotropic adenomas (<bold>D</bold>). For statistical details, please see <xref rid="T3" ref-type="table">Table 3</xref>.</p></caption><graphic xlink:href="CroatMedJ_61_0410-F1"/></fig><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Patients&#x02019; characteristics and surgical parameters for patients undergoing endoscopic (eTSS) or microsurgical transsphenoidal surgery (mTSS)*<sup>&#x02020;</sup></p></caption><table frame="hsides" rules="groups"><col width="113" span="1"/><col width="48" span="1"/><col width="48" span="1"/><col width="47" span="1"/><col width="48" span="1"/><col width="58" span="1"/><col width="53" span="1"/><col width="48" span="1"/><col width="53" span="1"/><col width="48" span="1"/><col width="53" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th valign="top" align="right" scope="col" rowspan="1" colspan="1">p</th><th valign="top" align="right" scope="col" rowspan="1" colspan="1">d</th><th valign="top" align="right" scope="col" rowspan="1" colspan="1">N</th><th valign="top" align="right" scope="col" rowspan="1" colspan="1">25q</th><th valign="top" align="right" scope="col" rowspan="1" colspan="1">Median</th><th valign="top" align="right" scope="col" rowspan="1" colspan="1">75q</th><th valign="top" align="right" scope="col" rowspan="1" colspan="1">Mean</th><th valign="top" align="right" scope="col" rowspan="1" colspan="1">SD</th><th valign="top" align="right" scope="col" rowspan="1" colspan="1">Min</th><th valign="top" align="right" scope="col" rowspan="1" colspan="1">Max</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Age (years)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">eTSS<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.7966<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.07<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">52<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">60<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">65<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">58.68<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">11.61<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">36<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">78<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">mTSS<hr/></td><td valign="top" colspan="1" align="right" rowspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">51<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">63<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">66<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">59.56<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">12.39<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">26<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">78<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Length of the follow-up (months)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">eTSS<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">&#x0003c;0.001<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1.14<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">15<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">20<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">28<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">23.6<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">11.93<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">12<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">57<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">mTSS<hr/></td><td valign="top" colspan="1" align="right" rowspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">27<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">39<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">46<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">37.16<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">11.75<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">18<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">55<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Preoperative volume (mm<sup>3</sup>)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">eTSS<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.2799<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.31<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">3910<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">6100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">8980<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">7830.6<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">5597.32<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">1810<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">23310<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">mTSS<hr/></td><td valign="top" colspan="1" align="right" rowspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">3005<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">3997<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">8580<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">6119.2<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">4640.92<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">1170<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">20700<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Postoperative volume (mm<sup>3</sup>)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">eTSS<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.7855<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.08<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">560<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">302.4<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">477.76<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">2020<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">mTSS<hr/></td><td valign="top" colspan="1" align="right" rowspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">210<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">445.44<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">1225.3<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">0<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">5890<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Volume reduction - overall (%)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">eTSS<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.9499<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.02<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">93<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">95.8<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">6.16<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">78<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">mTSS<hr/></td><td valign="top" colspan="1" align="right" rowspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">96<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">92.72<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">15.42<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">38<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Volume reduction &#x02013; group small (%)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">eTSS<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.9012<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.04<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">20<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">94.5<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">96.25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">5.95<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">78<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">mTSS<hr/></td><td valign="top" colspan="1" align="right" rowspan="1">19<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">96<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">92.63<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">17.04<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">38<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Volume reduction &#x02013; group large (%)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">eTSS<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">5<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">93<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">95<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">94<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">7.38<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">82<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">mTSS<hr/></td><td valign="top" colspan="1" align="right" rowspan="1">6<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">86.75<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">98.5<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">99.75<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">93<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">9.84<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">78<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Surgical time (min)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td colspan="9" valign="top" align="left" rowspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">eTSS<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">&#x0003c;0.001<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1.87<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">115<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">120<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">135<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">126.8<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">20.66<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">95<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">170<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">mTSS<hr/></td><td valign="top" colspan="1" align="right" rowspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">60<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">80<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">85<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">75.4<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">21.31<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">45<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">125<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Blood loss (mL)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">eTSS<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.0273<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.64<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">200<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">300<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">256<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">195.43<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">50<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">900<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">mTSS<hr/></td><td valign="top" colspan="1" align="right" rowspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">100<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">200<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">156<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">102.39<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">50<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">400<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>TVDT/Age</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">TVDT (days)<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.6773<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">0.09<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">2000.9<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">4334.25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">11048.6<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">7224<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">7341.62<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">502.46<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">26897.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">age (years)<hr/></td><td valign="top" colspan="1" align="right" rowspan="1">25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">56.25<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">64<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">66.5<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">61.32<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">11.23<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">37<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">78<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>TVDT/Ki-67 (days)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ki-67: 0-1<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">0.3472<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="right" rowspan="1" colspan="1">10<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">2520.7<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">8514.97<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">12902.1<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">8609.4<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">7772.31<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">535.83<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">23941.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ki-67: 1-2<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">0.4508<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="right" rowspan="1" colspan="1">9<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">1436.5<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">3433.09<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">6809.47<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">4465.9<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">3961.54<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">502.46<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">11504.4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ki-67: 2-3<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">0.5628<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="right" rowspan="1" colspan="1">6<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">2107<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">4234.72<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">10513<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">9143.5<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">10514.4<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">1965.5<hr/></td><td valign="top" align="right" rowspan="1" colspan="1">26897.4<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Endocrine functions</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td colspan="9" valign="top" align="left" rowspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">overall<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td colspan="9" valign="top" align="center" rowspan="1">Fisher exact test for count data: <italic>P</italic>&#x02009;=&#x02009;0.667<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">without initial deficit<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td colspan="9" valign="top" align="center" rowspan="1">Fisher exact test for count data: <italic>P</italic>&#x02009;=&#x02009;0.151<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">with initial deficit</td><td valign="top" align="left" rowspan="1" colspan="1"/><td colspan="9" valign="top" align="center" rowspan="1">Fisher exact test for count data: <italic>P</italic>&#x02009;=&#x02009;0.063<hr/></td></tr></tbody></table><table-wrap-foot><p>*TVDT &#x02013; tumor volume doubling time; SD &#x02013; standard deviation.</p><p>&#x02020;Consistency-radicality: Fisher exact test for count data: <italic>P</italic>&#x02009;=&#x02009;0.449.</p></table-wrap-foot></table-wrap><p>The extent of resection was evaluated on the postoperative MRI scans three months after surgery. The groups did not significantly differ in GTR, NTR, or STR resection (<xref ref-type="fig" rid="F2">Figure 2A</xref>). &#x0201c;Satisfactory resection,&#x0201d; defined in most research papers as GTR + NTR, was achieved in 18/25 (72%) patients in the eTSS group and 20/25 (80%) patients in the mTSS group, with no significant difference. No significant differences were also observed in overall volume reduction (<xref ref-type="fig" rid="F2">Figure 2B</xref> and <xref ref-type="fig" rid="F2">Figure 2C</xref>). To determine if the extent of the resection depended on the size of tumorous expansion, we performed a pair-to-pair analysis of &#x0201c;smaller NFPAs&#x0201d; (Hardy IA-IIB, Knosp 0-1) and &#x0201c;larger NFPAs&#x0201d; (Hardy IIC-IIIC, Knosp 2-3) but observed no significant differences between the groups (<xref ref-type="fig" rid="F2">Figure 2C</xref>).</p><fig id="F2" fig-type="figure" orientation="portrait" position="float"><label>Figure 2</label><caption><p>The extent of resection (no residual mass &#x02013; gross total resection [GTR]; &#x02264;5% of residual mass &#x02013; near-total resection [NTR]; and &#x02265;5% of residual mass &#x02013; sub-total resection[STR]) (<bold>A</bold>), residual postoperative volume (<bold>B</bold>), and volume reduction in subgroup analysis (<bold>C</bold>) showed no significant difference between the endoscopic (eTSS) or microsurgical (mTSS) transsphenoidal surgery group. For statistical details, please see <xref rid="T3" ref-type="table">Table 3</xref>.</p></caption><graphic xlink:href="CroatMedJ_61_0410-F2"/></fig><p>We compared the extent of resection with perioperatively reported tumor consistency. No tumor was graded as stiff. Despite a mild reduction of the total number of GTRs in the group of mixed tumors, no significant differences between eTSS or mTSS groups were observed (<xref ref-type="fig" rid="F3">Figure 3A</xref>).</p><fig id="F3" fig-type="figure" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Tumor stiffness can greatly affect the resection feasibility. In both surgical groups we achieved similar rate of resection in accordance with the type of tumor (<bold>A</bold>). The endoscopic transsphenoidal surgery (eTSS) group had significantly longer duration of surgery (<bold>B</bold>) and perioperatively-reported blood loss (<bold>C</bold>). For statistical details, please see <xref rid="T3" ref-type="table">Table 3</xref>. GTR &#x02013; gross total resection, NTR &#x02013; near-total resection, STR &#x02013; sub-total resection. * <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, *** <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001.</p></caption><graphic xlink:href="CroatMedJ_61_0410-F3"/></fig><p>Data on surgery duration and blood loss were obtained from the anesthesia records. The groups significantly differed in mean time of the surgery: 127 minutes in the eTSS vs 75 minutes in the mTSS group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) (<xref ref-type="fig" rid="F3">Figure 3B</xref>). The shorter operating time was associated with significantly lower blood loss in the mTSS group (156 mL) compared with the eTSS group (256 mL) (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.027) (<xref ref-type="fig" rid="F3">Figure 3C</xref>).</p><p>TVDT was calculated logarithmically according to the volume of the residual tumorous mass (present in 44% of cases) on postoperative MRI scans. We found no significant correlation between TVDT and patient's age and Ki-67 index (<xref ref-type="fig" rid="F4">Figure 4A</xref> and <xref ref-type="fig" rid="F4">Figure 4B</xref>). Two patients with Ki-67&#x02009;&#x0003e;&#x02009;3% showed no signs of relapse during the follow-up. Two more patients (n<sub>eTSS</sub>&#x02009;=&#x02009;1, n<sub>mTSS</sub>&#x02009;=&#x02009;1) were referred for Leksell gamma knife therapy due to graphical progression of residual disease.</p><fig id="F4" fig-type="figure" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Tumor volume doubling time (TVDT) showed no correlation with age (<bold>A</bold>) or Ki-67 index (<bold>B</bold>). For statistical details, please see <xref rid="T3" ref-type="table">Table 3</xref>.</p></caption><graphic xlink:href="CroatMedJ_61_0410-F4"/></fig><p>Preoperative visual problems were present in 24/50 (48%) patients, with the majority of them in the eTSS group (17/24 &#x02013; 70.8%). Most of patients reported subjective improvement in visual acuity three months after surgery, and all patients reported improvement 12 months after surgery. There was no significant difference between the groups.</p><p>Chiasmatic syndrome was preoperatively observed in 54% of patients (n<sub>eTSS</sub>&#x02009;=&#x02009;19, n<sub>mTSS</sub>&#x02009;=&#x02009;8). In the eTSS group, 17 patients reported subjective improvement three months after surgery, 1 patient reported partial improvement 12 months after surgery, and 1 patient, who had pupillary atrophic changes, reported no improvement. In the mTSS group, all patients reported improvement three months after surgery. Despite subjective improvement in the visual field in 26/27 (96.3%) of patients, ophthalmological examination detected discrete blackspots in 4/19 (21%) patients in the eTSS group and 2/8 (25%) patients in the mTSS group, without significant differences between the groups.</p><p>The complete preoperative hormonal profile was compared with the hormonal profile 12 months after surgery to evaluate the endocrine functions. At least one hormonal function improved in 10/25 (40%) of patients in the eTSS and in 7/25 (28%) patients in the mTSS group. No difference in the hormonal profile was identified in 10/25 (40%) patients in the eTSS and 13/25 (52%) of patients in the mTSS group. The remaining 5/25 (20%) of patients in both groups experienced a deterioration in hormonal profile (<xref ref-type="fig" rid="F5">Figure 5A</xref>). We compared the subgroups with or without initial hormonal deficit. In patients without initial deficit we observed a trend toward postoperative improvement of endocrine functions (<italic>P</italic>&#x02009;=&#x02009;0.15) (<xref ref-type="fig" rid="F5">Figure 5B</xref>). In patients with a deficit, no improvement was observed (<xref ref-type="fig" rid="F5">Figure 5C</xref>). No significant difference between the groups was found.</p><fig id="F5" fig-type="figure" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Evaluation of endocrine functions was performed one year after surgery. No significant difference was observed between the groups (<bold>A</bold>). In the subgroup of patients without preoperatively described hormonal deficit, a trend toward improved hormonal profile was observed (<bold>B</bold>). The majority of patients with an initially deteriorated hormonal profile remained hormonally stable (<bold>C</bold>). For statistical details, please see <xref rid="T3" ref-type="table">Table 3</xref>.</p></caption><graphic xlink:href="CroatMedJ_61_0410-F5"/></fig><p>Seven patients developed postoperative diabetes insipidus (DI). One patient in the eTSS group developed DI 6 months after surgery. Interestingly, no associated image was found on MRI. Another patient developed syndrome of inappropriate antidiuretic hormone release one month after surgery, requiring sodium supplementation. No significant difference in the number of patients with DI or SIADH was found between the groups, even in the subgroup analysis.</p><p>In both groups we identified four major complications in the postoperative period (8% rate). One patient from the eTSS group experienced epistaxis, which was resolved during the hospitalization. Three patients developed sphenoidal sinusitis treated by local and systemic antibiotic administration. Two of them, one from each group, were successfully treated during 3-12 months after surgery. One additional patient from the mTSS group was successfully treated within 14 months after surgery. Other minor complications were equally distributed in both groups, with no significant difference (<xref rid="T2" ref-type="table">Table 2</xref>). Liquorrhea, which was present during the operation in 15 patients (n<sub>eTSS</sub>&#x02009;=&#x02009;7, n<sub>mTSS</sub>&#x02009;=&#x02009;8), was never detected in the postoperative period.</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>The number of minor complications in patients with non-functioning pituitary adenomas who underwent endoscopic (eTSS) or microsurgical transsphenoidal surgery (mTSS)</p></caption><table frame="hsides" rules="groups"><col width="130" span="1"/><col width="36" span="1"/><col width="36" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><sub>eTSS</sub></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><sub>mTSS</sub></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nose odor<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Serous secretion<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mucosa thickening (MRI)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Serous filling of the sphenoid cavity (MRI)</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">3</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>The study results showed that eTSS and mTSS had comparable extent of resection, overall clinical or hormonal effect, and complication rate. However, minor differences linked to specific conditions used in our study were found in surgical time and blood loss.</p><p>Although a number of studies compared eTSS and mTSS, many of them were criticized for methodological errors, retrospective character, variable definition of radicality of the surgery, or questionable interpretation of visual and hormonal improvement. Moreover, learning curves in the new operating technique considerably vary. Indeed, it is often neglected that surgical experience is probably the most important factor in predicting a favorable outcome (<xref rid="R24" ref-type="bibr">24</xref>-<xref rid="R26" ref-type="bibr">26</xref>). Familiarization with an endoscope is a difficult and long process due to two dimensional viewing, an absence of depth perception, barrel effect, and clashing instruments. The learning curve for fully endoscopic TSS is between 17 and 34 cases (<xref rid="R27" ref-type="bibr">27</xref>). In the light of the learning curve, our results reflect the the greater experience of the surgeon in mTSS than the relatively new eTSS method. These results are comparable with the similarly designed TRANSSPHER study (<xref rid="R18" ref-type="bibr">18</xref>).</p><p>Generally, radicality of the surgery often depends on tumor size. In mTSS GTR usually ranges from 50% to 75%, whereas in eTSS it ranges from 55% to 95% (<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R28" ref-type="bibr">28</xref>-<xref rid="R33" ref-type="bibr">33</xref>). A recently published meta-analysis by Almutairi et al, involving nearly 2700 patients, found a significant difference between the techniques, favoring eTSS with 71% of GTR resections against 60.7% in mTSS (<xref rid="R14" ref-type="bibr">14</xref>). On the other hand, other authors have failed to prove higher radicality in eTSS (<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R34" ref-type="bibr">34</xref>-<xref rid="R36" ref-type="bibr">36</xref>). This finding is consistent with our results. Reduction of the tumorous mass and the GTR/NTR/STR ratio were similar in both groups. Satisfactory resection, defined as &#x02265;95% reduction in tumor volume was achieved in 72% of eTSS patients and 80% of mTSS patients, a difference that is not significant. Also, unlike other authors, we did not find any significant correlation in the subgroups consisting of only less/more invasive or small/large tumors (<xref rid="R37" ref-type="bibr">37</xref>,<xref rid="R38" ref-type="bibr">38</xref>). Nevertheless, there was a mild 15% decrease in surgical radicality in the subgroup of invasive NFPAs vs non-invasive NFPAs. Our study indicates that mTSS can be used to successfully treat even NFPAs with more-invasive parasellar behavior. In this respect, we suggest the use of bayonet mirrors, which are very effective in searching for residual tumorous mass.</p><p>Despite a mild trend, we also did not observe that tumor consistency depended on surgical radicality. This is probably due to the absence of stiff tumors and the preponderance of mixed tumors, which are relatively &#x0201c;easy&#x0201d; to remove.</p><p>A significant difference was observed in surgery duration, which was shorter in the mTSS group. Also, mTSS group had a significantly lower blood loss. Both these findings are in contrast to the results of some previous studies (<xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R39" ref-type="bibr">39</xref>) but are in agreement with those of the TRANSSPHER study (<xref rid="R18" ref-type="bibr">18</xref>). Our findings may be explained by the fact that the larger surgical corridor required in the endoscopic technique, involving time-consuming fenestration of the sphenoid cavity, is performed using the binostral approach. Mastering this technique will probably shorten the surgical time in the eTSS group, as well as the blood loss volume.</p><p>Unlike our previous study, this study did not demonstrate any correlation between the growth rate of the residual mass and age or Ki-67 antigen expression (<xref rid="R40" ref-type="bibr">40</xref>). However, we believe that previously published growth-rate correlations with Ki-67 have prognostic significance (<xref rid="R41" ref-type="bibr">41</xref>-<xref rid="R47" ref-type="bibr">47</xref>). It is still a matter of debate whether the limit of 3% of Ki-67 expression proposed by the European Society of Endocrinology is correctly set (<xref rid="R48" ref-type="bibr">48</xref>-<xref rid="R50" ref-type="bibr">50</xref>). In our opinion, longitudinal prediction of the growth rate of TVDT is an important tool for tailoring the follow-up for surgically as well as conservatively treated patients.</p><p>The literature points to major discrepancies in the classification of visual impairments, a problem leading to questionable results interpretation. The effect of the surgery is closely associated with the duration of visual problems, the trophic status of the optic nerves, and comorbidities such as diabetes or arterial hypertension (<xref rid="R51" ref-type="bibr">51</xref>,<xref rid="R52" ref-type="bibr">52</xref>). In accordance with other studies, we did not find any significant differences between the methods (<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R38" ref-type="bibr">38</xref>,<xref rid="R53" ref-type="bibr">53</xref>,<xref rid="R54" ref-type="bibr">54</xref>). The similar results obtained for both techniques can be attributed to the visual outcome primarily depending on the timing and decompression of the optic apparatus rather than on the extent of the resection itself. Decreased visual acuity, which was reported pre-operatively in 48% of our patients (60% of them in the eTSS group), was improved within the first three months after surgery in 94% of the patients in the eTSS group and in 71.4% of the patients in the mTSS group. One year after surgery, the improvement was observed in all patients. Similarly, chiasmatic syndrome was improved in 96% of patients. These results are in agreement with those of other authors, who reported improvement in 91%-94.7% of patients (<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R55" ref-type="bibr">55</xref>). Unlike these authors, we did not register any patient with postsurgical visual impairment. Temporary paresis of cranial nerves (abducent and oculomotor nerves) present in three patients was the result of pituitary apoplexy and spontaneously regressed within three months.</p><p>Endocrine functions were improved in at least one hormonal function in 34% of patients, with no significant difference between the groups, but with a mild trend favoring the eTSS method. The endoscopic technique is commonly associated with better hormonal outcomes than mTSS (<xref rid="R56" ref-type="bibr">56</xref>-<xref rid="R58" ref-type="bibr">58</xref>). In contrast, Nomikos et al, in a large series of 660 patients, reported excellent results for mTSS, with nearly 50% improvement and only 1.4% impairment (<xref rid="R59" ref-type="bibr">59</xref>). Other studies reported more realistic results &#x02013; 25%-35% improvement and 29%-32% impairment (<xref rid="R60" ref-type="bibr">60</xref>,<xref rid="R61" ref-type="bibr">61</xref>).</p><p>In our study, surgical complications were equally distributed in both groups. Rhinological complications (bleeding, inflammation) were noted in fewer than 8%, and minor subjective complaints involving nasal discomfort or temporary secretion in 16% of the patients. A higher incidence of postoperative sinusitis after mTSS often mentioned in other studies was not observed in our study. We also do not agree with the rare opinion that microsurgical retraction increases the rate of ischemia of the sinoatrial complex (<xref rid="R62" ref-type="bibr">62</xref>,<xref rid="R63" ref-type="bibr">63</xref>). Moreover, most of the complications of mTSS were reported when sublabial approach was used, which has been abandoned and replaced by the more gentle paraseptal approach (<xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R64" ref-type="bibr">64</xref>-<xref rid="R66" ref-type="bibr">66</xref>).</p><p>Postoperative liquorrhea occurrence in mTSS ranges from 1%-3%, with a higher incidence in eTSS (<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R67" ref-type="bibr">67</xref>). Despite a relatively high incidence of peri-operative liquorrhea (30%), we did not observe any postoperative leakage or meningitis, which implies very good sealing of the communication. We also did not register any postoperative visual deficit or major arterial infarction (<xref rid="R68" ref-type="bibr">68</xref>-<xref rid="R70" ref-type="bibr">70</xref>). Temporary DI was observed in 14% of patients, whereas no patients experienced permanent DI. Permanent DI is reported in 2%-10% of patients undergoing mTSS and in 0%-2% of patients undergoing eTSS (<xref rid="R20" ref-type="bibr">20</xref>). In our study, up to 20% patients needed postoperative introduction or increase in hormonal substitutional therapy, a finding that is in agreement with other studies (<xref rid="R71" ref-type="bibr">71</xref>,<xref rid="R72" ref-type="bibr">72</xref>).</p><p>The results of this study have to be interpreted in the light of some limitations. The main limitation is the retrospective study design, which inevitably leads to selection bias. Furthermore, given that eTSS is a recently introduced method, higher surgical experience rate could be expected with the older mTSS method.</p><p>In conclusion, our retrospective comparative analysis of transsphenoidal mTSS and eTSS resections of collected NFPAs showed similar results for both procedures in terms of the extent of resection, safeness of the procedures, and overall clinical effect on visual and hormonal functions. mTSS showed significant benefit in terms of surgical time and blood loss. On the other hand, eTSS mildly improved hormonal functions. Despite the overall acceptable surgical outcomes in both techniques, we expect that results of eTSS will improve with increasing experience, and thus this study generally supports our transition to endoscopic pituitary surgery, especially in the cases of large extra- and parasellar tumor extension.</p></sec></body><back><ack><p>Funding This study was supported by the project MH CZ NV19-01-00435 and PROGRES Q40.</p><p>Ethical approval given by the Ethics Committee of the University Hospital Hradec Kralove (202010 P06).</p><p>Declaration of authorship TC: study conception and design, surgery, collection and/or assembly of data, data analysis and interpretation, manuscript writing, final approval of the manuscript; PP: surgery, collection and/or assembly of data, data analysis and interpretation, final approval of the manuscript; JA: collection and/or assembly of data, final approval of the manuscript; PC: surgery, final approval of the manuscript; FG: collection and/or assembly of data, final approval of the manuscript; JS: collection and/or assembly of data, final approval of the manuscript; RD: collection and/or assembly of data, final approval of the manuscript; PK: data analysis and interpretation, manuscript writing, final approval of the manuscript. All authors critically revised the manuscript for important intellectual content; all authors gave approval of the version to be submitted; all authors agree to be accountable for all aspects of the work.</p><p>Competing interests All authors have completed the Unified Competing Interest form at <ext-link ext-link-type="uri" xlink:href="http://www.icmje.org/coi_disclosure.pdf">www.icmje.org/coi_disclosure.pdf</ext-link> (available on request from the corresponding author) and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships.</p></ack><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Ludecke</surname><given-names>DK</given-names></name><name><surname>Saeger</surname><given-names>W</given-names></name></person-group><article-title>Clinically nonsecreting pituitary adenomas in childhood and adolescence.</article-title><source>Neurosurgery</source><year>1998</year><volume>42</volume><fpage>744</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1097/00006123-199804000-00037</pub-id><pub-id pub-id-type="pmid">9574638</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacs</surname><given-names>K</given-names></name><name><surname>Ryan</surname><given-names>N</given-names></name><name><surname>Horvath</surname><given-names>E</given-names></name><name><surname>Singer</surname><given-names>W</given-names></name><name><surname>Ezrin</surname><given-names>C</given-names></name></person-group><article-title>Pituitary adenomas in old age.</article-title><source>J Gerontol</source><year>1980</year><volume>35</volume><fpage>16</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1093/geronj/35.1.16</pub-id><pub-id pub-id-type="pmid">6243145</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shou</surname><given-names>XF</given-names></name><name><surname>Li</surname><given-names>SQ</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>PF</given-names></name><name><surname>Zhou</surname><given-names>LF</given-names></name></person-group><article-title>Treatment of pituitary adenomas with a transsphenoidal approach.</article-title><source>Neurosurgery</source><year>2005</year><volume>56</volume><fpage>249</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1227/01.NEU.0000147976.06937.1D</pub-id><pub-id pub-id-type="pmid">15670373</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>BY</given-names></name><name><surname>Castillo</surname><given-names>M</given-names></name></person-group><article-title>Nonadenomatous tumors of the pituitary and sella turcica.</article-title><source>Top Magn Reson Imaging</source><year>2005</year><volume>16</volume><fpage>289</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1097/01.rmr.0000224685.83629.18</pub-id><pub-id pub-id-type="pmid">16785844</pub-id></element-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="book">&#x0010c;es&#x000e1;k T, N&#x000e1;hlovsk&#x000fd; J, L&#x000e1;tr I, &#x0010c;&#x000e1;p J, Ry&#x00161;ka P. N&#x000e1;dorov&#x000e1; onemocn&#x0011b;n&#x000ed; hypof&#x000fd;zy. In: N&#x000e1;hlovsk&#x000fd; J. Neurochirurgie Praha: Gal&#x000e9;n; 2006: p 155-174.</mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="book">Lloyd RV, Osamura RY, Kl&#x000f6;ppel G, Rosai J, Bosman FT, Jaffe ES, et al. WHO classification of tumours of endocrine organs. International Agency for Research on Cancer. 2017.</mixed-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ntali</surname><given-names>G</given-names></name><name><surname>Wass</surname><given-names>JA</given-names></name></person-group><article-title>Epiemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.</article-title><source>Pituitary</source><year>2018</year><volume>21</volume><fpage>111</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s11102-018-0869-3</pub-id><pub-id pub-id-type="pmid">29368293</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tjornstrand</surname><given-names>A</given-names></name><name><surname>Gunnarsson</surname><given-names>K</given-names></name><name><surname>Evert</surname><given-names>M</given-names></name><name><surname>Holmberg</surname><given-names>E</given-names></name><name><surname>Ragnarsson</surname><given-names>O</given-names></name><name><surname>Rosen</surname><given-names>T</given-names></name><etal/></person-group><article-title>The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.</article-title><source>Eur J Endocrinol</source><year>2014</year><volume>171</volume><fpage>519</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1530/EJE-14-0144</pub-id><pub-id pub-id-type="pmid">25084775</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname><given-names>DS</given-names></name><name><surname>Nilsson</surname><given-names>AG</given-names></name><name><surname>Bryngelsson</surname><given-names>IL</given-names></name><name><surname>Trimpou</surname><given-names>P</given-names></name><name><surname>Johannsson</surname><given-names>G</given-names></name><name><surname>Andersson</surname><given-names>E</given-names></name></person-group><article-title>Excess mortality in women and young adults with nonfunctioning pituitary adenoma: a Swedish nationwide study.</article-title><source>J Clin Endocrinol Metab</source><year>2015</year><volume>100</volume><fpage>2651</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1210/jc.2015-1475</pub-id><pub-id pub-id-type="pmid">25946030</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciric</surname><given-names>I</given-names></name><name><surname>Ragin</surname><given-names>A</given-names></name><name><surname>Baumgartner</surname><given-names>C</given-names></name><name><surname>Pierce</surname><given-names>D</given-names></name></person-group><article-title>Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience.</article-title><source>Neurosurgery</source><year>1997</year><volume>40</volume><fpage>225</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1097/00006123-199702000-00001</pub-id><pub-id pub-id-type="pmid">9007854</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>J</given-names></name></person-group><article-title>Transsphenoidal hypophysectomy.</article-title><source>J Neurosurg</source><year>1971</year><volume>34</volume><fpage>582</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.3171/jns.1971.34.4.0582</pub-id><pub-id pub-id-type="pmid">5554367</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>SK</given-names></name><name><surname>Husain</surname><given-names>Q</given-names></name><name><surname>Eloy</surname><given-names>JA</given-names></name><name><surname>Couldwell</surname><given-names>WT</given-names></name><name><surname>Liu</surname><given-names>JK</given-names></name></person-group><article-title>Norman Dott, Gerard Guiot, and Jules Hardy: key players in the resurrection and preservation of transsphenoidal surgery.</article-title><source>Neurosurg Focus</source><year>2012</year><volume>33</volume><elocation-id>E6</elocation-id><pub-id pub-id-type="doi">10.3171/2012.6.FOCUS12125</pub-id><pub-id pub-id-type="pmid">22853837</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>CB</given-names></name></person-group><article-title>Surgical management of pituitary tumors.</article-title><source>J Clin Endocrinol Metab</source><year>1997</year><volume>82</volume><fpage>2381</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1210/jcem.82.8.4188</pub-id><pub-id pub-id-type="pmid">9253304</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almutairi</surname><given-names>RD</given-names></name><name><surname>Muskens</surname><given-names>IS</given-names></name><name><surname>Cote</surname><given-names>DJ</given-names></name><name><surname>Dijkman</surname><given-names>MD</given-names></name><name><surname>Kavouridis</surname><given-names>VK</given-names></name><name><surname>Crocker</surname><given-names>E</given-names></name><etal/></person-group><article-title>Gross total resection of pituitary adenomas after endoscopic vs microscopic transsphenoidal surgery: a meta-analysis.</article-title><source>Acta Neurochir (Wien)</source><year>2018</year><volume>160</volume><fpage>1005</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1007/s00701-017-3438-z</pub-id><pub-id pub-id-type="pmid">29307020</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cappabianca</surname><given-names>P</given-names></name><name><surname>Alfieri</surname><given-names>A</given-names></name><name><surname>de Divitiis</surname><given-names>E</given-names></name></person-group><article-title>Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS).</article-title><source>Minim Invasive Neurosurg</source><year>1998</year><volume>41</volume><fpage>66</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1055/s-2008-1052019</pub-id><pub-id pub-id-type="pmid">9651913</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dallapiazza</surname><given-names>RF</given-names></name><name><surname>Jane</surname><given-names>JA</given-names><suffix>Jr</suffix></name></person-group><article-title>Outcomes of endoscopic transsphenoidal pituitary surgery.</article-title><source>Endocrinol Metab Clin North Am</source><year>2015</year><volume>44</volume><fpage>105</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.ecl.2014.10.010</pub-id><pub-id pub-id-type="pmid">25732647</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dusick</surname><given-names>JR</given-names></name><name><surname>Esposito</surname><given-names>F</given-names></name><name><surname>Mattozo</surname><given-names>CA</given-names></name><name><surname>Chaloner</surname><given-names>C</given-names></name><name><surname>McArthur</surname><given-names>DL</given-names></name><name><surname>Kelly</surname><given-names>DF</given-names></name></person-group><article-title>Endonasal transsphenoidal surgery: the patient&#x02019;s perspective-survey results from 259 patients.</article-title><source>Surg Neurol</source><year>2006</year><volume>65</volume><fpage>332</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.surneu.2005.12.010</pub-id><pub-id pub-id-type="pmid">16531188</pub-id></element-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Little</surname><given-names>AS</given-names></name><name><surname>Kelly</surname><given-names>DF</given-names></name><name><surname>White</surname><given-names>WL</given-names></name><name><surname>Gardner</surname><given-names>PA</given-names></name><name><surname>Fernandez-Miranda</surname><given-names>JC</given-names></name><etal/></person-group>Results of a prospective multicenter controlled study comparing surgical outcomes of microscopic versus fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas: the Transsphenoidal Extent of Resection (TRANSSPHER)<source>Study J Neurosurg</source><year>2019</year><fpage>1</fpage><lpage>11</lpage></mixed-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poczos</surname><given-names>P</given-names></name><name><surname>Kurbanov</surname><given-names>A</given-names></name><name><surname>Keller</surname><given-names>JT</given-names></name><name><surname>Zimmer</surname><given-names>LA</given-names></name></person-group><article-title>Medial and superior orbital decompression: improving access for endonasal endoscopic frontal sinus surgery.</article-title><source>Ann Otol Rhinol Laryngol</source><year>2015</year><volume>124</volume><fpage>987</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1177/0003489415595423</pub-id><pub-id pub-id-type="pmid">26180177</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabaee</surname><given-names>A</given-names></name><name><surname>Anand</surname><given-names>VK</given-names></name><name><surname>Barron</surname><given-names>Y</given-names></name><name><surname>Hiltzik</surname><given-names>DH</given-names></name><name><surname>Brown</surname><given-names>SM</given-names></name><name><surname>Kacker</surname><given-names>A</given-names></name><etal/></person-group><article-title>Endoscopic pituitary surgery: a systematic review and meta-analysis.</article-title><source>J Neurosurg</source><year>2009</year><volume>111</volume><fpage>545</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.3171/2007.12.17635</pub-id><pub-id pub-id-type="pmid">19199461</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipina</surname><given-names>MR</given-names></name><name><surname>Matou&#x00161;ek</surname><given-names>MP</given-names></name><name><surname>Pale&#x0010d;ek</surname><given-names>MT</given-names></name></person-group><article-title>Endoskopick&#x000fd; transnaz&#x000e1;ln&#x000ed; p&#x00159;&#x000ed;stup k l&#x000e9;z&#x000ed;m sel&#x000e1;rn&#x000ed; oblasti.</article-title><source>Endoskopie.</source><year>2011</year><volume>20</volume><fpage>57</fpage><lpage>61</lpage></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knosp</surname><given-names>E</given-names></name><name><surname>Steiner</surname><given-names>E</given-names></name><name><surname>Kitz</surname><given-names>K</given-names></name><name><surname>Matula</surname><given-names>C</given-names></name></person-group><article-title>Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings.</article-title><source>Neurosurgery</source><year>1993</year><volume>33</volume><fpage>610</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1227/00006123-199310000-00008</pub-id><pub-id pub-id-type="pmid">8232800</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Hongo</surname><given-names>K</given-names></name><name><surname>Tada</surname><given-names>T</given-names></name><name><surname>Sakai</surname><given-names>K</given-names></name><name><surname>Kakizawa</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>S</given-names></name></person-group><article-title>Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.</article-title><source>J Neurosurg</source><year>2003</year><volume>98</volume><fpage>359</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.3171/jns.2003.98.2.0359</pub-id><pub-id pub-id-type="pmid">12593623</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asemota</surname><given-names>AO</given-names></name><name><surname>Ishii</surname><given-names>M</given-names></name><name><surname>Brem</surname><given-names>H</given-names></name><name><surname>Gallia</surname><given-names>GL</given-names></name></person-group><article-title>Comparison of complications, trends, and costs in endoscopic vs microscopic pituitary surgery: analysis from a US Health Claims Database.</article-title><source>Neurosurgery</source><year>2017</year><volume>81</volume><fpage>458</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1093/neuros/nyx350</pub-id><pub-id pub-id-type="pmid">28859453</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bokhari</surname><given-names>AR</given-names></name><name><surname>Davies</surname><given-names>MA</given-names></name><name><surname>Diamond</surname><given-names>T</given-names></name></person-group><article-title>Endoscopic transsphenoidal pituitary surgery: a single surgeon experience and the learning curve.</article-title><source>Br J Neurosurg</source><year>2013</year><volume>27</volume><fpage>44</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.3109/02688697.2012.709554</pub-id><pub-id pub-id-type="pmid">22900510</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Ge</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name></person-group><article-title>A learning curve of endoscopic transsphenoidal surgery for pituitary adenoma.</article-title><source>J Craniofac Surg</source><year>2013</year><volume>24</volume><fpage>2064</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/SCS.0b013e3182a24328</pub-id><pub-id pub-id-type="pmid">24220407</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SJ</given-names></name><name><surname>Eralil</surname><given-names>G</given-names></name><name><surname>Woon</surname><given-names>K</given-names></name><name><surname>Sama</surname><given-names>A</given-names></name><name><surname>Dow</surname><given-names>G</given-names></name><name><surname>Robertson</surname><given-names>I</given-names></name></person-group><article-title>Light at the end of the tunnel: the learning curve associated with endoscopic transsphenoidal skull base surgery.</article-title><source>Skull Base</source><year>2010</year><volume>20</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1055/s-0029-1238214</pub-id><pub-id pub-id-type="pmid">20808530</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassis</surname><given-names>S</given-names></name><name><surname>De Battista</surname><given-names>JC</given-names></name><name><surname>Raverot</surname><given-names>G</given-names></name><name><surname>Jacob</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>E</given-names></name><name><surname>Rabilloud</surname><given-names>M</given-names></name><etal/></person-group><article-title>Endoscopy versus microsurgery: results in a consecutive series of nonfunctioning pituitary adenomas. </article-title><source>Neurochirurgie</source><year>2009</year><volume>55</volume><fpage>607</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.neuchi.2009.05.003</pub-id><pub-id pub-id-type="pmid">19733369</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkmann</surname><given-names>S</given-names></name><name><surname>Schlaffer</surname><given-names>S</given-names></name><name><surname>Nimsky</surname><given-names>C</given-names></name><name><surname>Fahlbusch</surname><given-names>R</given-names></name><name><surname>Buchfelder</surname><given-names>M</given-names></name></person-group><article-title>Follow-up and long-term outcome of nonfunctioning pituitary adenoma operated by transsphenoidal surgery with intraoperative high-field magnetic resonance imaging.</article-title><source>Acta Neurochir (Wien)</source><year>2014</year><volume>156</volume><fpage>2233</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1007/s00701-014-2210-x</pub-id><pub-id pub-id-type="pmid">25174805</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Divitiis</surname><given-names>E</given-names></name><name><surname>Cappabianca</surname><given-names>P</given-names></name></person-group><article-title>Endoscopic endonasal transsphenoidal surgery.</article-title><source>Adv Tech Stand Neurosurg</source><year>2002</year><volume>27</volume><fpage>137</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/978-3-7091-6174-6_4</pub-id><pub-id pub-id-type="pmid">11887578</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehdashti</surname><given-names>AR</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Karabatsou</surname><given-names>K</given-names></name><name><surname>Gentili</surname><given-names>F</given-names></name></person-group><article-title>Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series.</article-title><source>Neurosurgery</source><year>2008</year><volume>62</volume><fpage>1006</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1227/01.neu.0000325862.83961.12</pub-id><pub-id pub-id-type="pmid">18580798</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeKlotz</surname><given-names>TR</given-names></name><name><surname>Chia</surname><given-names>SH</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Makambi</surname><given-names>KH</given-names></name><name><surname>Aulisi</surname><given-names>E</given-names></name><name><surname>Deeb</surname><given-names>Z</given-names></name></person-group><article-title>Meta-analysis of endoscopic versus sublabial pituitary surgery.</article-title><source>Laryngoscope</source><year>2012</year><volume>122</volume><fpage>511</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/lary.22479</pub-id><pub-id pub-id-type="pmid">22252670</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortini</surname><given-names>P</given-names></name><name><surname>Losa</surname><given-names>M</given-names></name><name><surname>Barzaghi</surname><given-names>R</given-names></name><name><surname>Boari</surname><given-names>N</given-names></name><name><surname>Giovanelli</surname><given-names>M</given-names></name></person-group><article-title>Results of transsphenoidal surgery in a large series of patients with pituitary adenoma.</article-title><source>Neurosurgery</source><year>2005</year><volume>56</volume><fpage>1222</fpage><lpage>33, discussion 1233</lpage><pub-id pub-id-type="doi">10.1227/01.NEU.0000159647.64275.9D</pub-id><pub-id pub-id-type="pmid">15918938</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotenberg</surname><given-names>B</given-names></name><name><surname>Tam</surname><given-names>S</given-names></name><name><surname>Ryu</surname><given-names>WH</given-names></name><name><surname>Duggal</surname><given-names>N</given-names></name></person-group><article-title>Microscopic versus endoscopic pituitary surgery: a systematic review.</article-title><source>Laryngoscope</source><year>2010</year><volume>120</volume><fpage>1292</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/lary.20949</pub-id><pub-id pub-id-type="pmid">20578228</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Essayed</surname><given-names>WI</given-names></name><name><surname>Cohen-Gadol</surname><given-names>A</given-names></name><name><surname>Zada</surname><given-names>G</given-names></name><name><surname>Schwartz</surname><given-names>TH</given-names></name></person-group><article-title>Resection of pituitary tumors: endoscopic versus microscopic.</article-title><source>J Neurooncol</source><year>2016</year><volume>130</volume><fpage>309</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1007/s11060-016-2124-y</pub-id><pub-id pub-id-type="pmid">27161249</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strychowsky</surname><given-names>J</given-names></name><name><surname>Nayan</surname><given-names>S</given-names></name><name><surname>Reddy</surname><given-names>K</given-names></name><name><surname>Farrokhyar</surname><given-names>F</given-names></name><name><surname>Sommer</surname><given-names>D</given-names></name></person-group><article-title>Purely endoscopic transsphenoidal surgery versus traditional microsurgery for resection of pituitary adenomas: systematic review.</article-title><source>J Otolaryngol Head Neck Surg</source><year>2011</year><volume>40</volume><fpage>175</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">21453654</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhandapani</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Negm</surname><given-names>HM</given-names></name><name><surname>Cohen</surname><given-names>S</given-names></name><name><surname>Anand</surname><given-names>VK</given-names></name><name><surname>Schwartz</surname><given-names>TH</given-names></name></person-group><article-title>cavernous sinus invasion in pituitary adenomas: systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery.</article-title><source>World Neurosurg</source><year>2016</year><volume>96</volume><fpage>36</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2016.08.088</pub-id><pub-id pub-id-type="pmid">27591098</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messerer</surname><given-names>M</given-names></name><name><surname>De Battista</surname><given-names>JC</given-names></name><name><surname>Raverot</surname><given-names>G</given-names></name><name><surname>Kassis</surname><given-names>S</given-names></name><name><surname>Dubourg</surname><given-names>J</given-names></name><name><surname>Lapras</surname><given-names>V</given-names></name><etal/></person-group><article-title>Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal.</article-title><source>Neurosurg Focus</source><year>2011</year><volume>30</volume><elocation-id>E11</elocation-id><pub-id pub-id-type="doi">10.3171/2011.1.FOCUS10308</pub-id><pub-id pub-id-type="pmid">21456922</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>C</given-names></name><etal/></person-group><article-title>Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: a meta-analysis.</article-title><source>World J Surg Oncol</source><year>2014</year><volume>12</volume><fpage>94</fpage><pub-id pub-id-type="doi">10.1186/1477-7819-12-94</pub-id><pub-id pub-id-type="pmid">24721812</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x0010c;es&#x000e1;k</surname><given-names>T</given-names></name><name><surname>N&#x000e1;hlovsk&#x000fd;</surname><given-names>J</given-names></name><name><surname>Hossz&#x000fa;</surname><given-names>T</given-names></name><name><surname>&#x00158;eh&#x000e1;k</surname><given-names>S</given-names></name><name><surname>L&#x000e1;tr</surname><given-names>I</given-names></name><name><surname>N&#x0011b;me&#x0010d;ek</surname><given-names>S</given-names></name><etal/></person-group><article-title>Longitudin&#x000e1;ln&#x000ed; sledov&#x000e1;n&#x000ed; r&#x0016f;stu poopera&#x0010d;n&#x000ed;ch rezidu&#x000ed; afunk&#x0010d;n&#x000ed;ch adenom&#x0016f; hypof&#x000fd;zy.</article-title><source>Cesk Slov Neurol.</source><year>2009</year><volume>72</volume><fpage>105</fpage></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gejman</surname><given-names>R</given-names></name><name><surname>Swearingen</surname><given-names>B</given-names></name><name><surname>Hedley-Whyte</surname><given-names>ET</given-names></name></person-group><article-title>Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas.</article-title><source>Hum Pathol</source><year>2008</year><volume>39</volume><fpage>758</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.humpath.2007.10.004</pub-id><pub-id pub-id-type="pmid">18439942</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honegger</surname><given-names>J</given-names></name><name><surname>Prettin</surname><given-names>C</given-names></name><name><surname>Feuerhake</surname><given-names>F</given-names></name><name><surname>Petrick</surname><given-names>M</given-names></name><name><surname>Schulte-Monting</surname><given-names>J</given-names></name><name><surname>Reincke</surname><given-names>M</given-names></name></person-group><article-title>Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness.</article-title><source>J Neurosurg</source><year>2003</year><volume>99</volume><fpage>674</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.3171/jns.2003.99.4.0674</pub-id><pub-id pub-id-type="pmid">14567602</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>DW</given-names></name><name><surname>Hakim</surname><given-names>F</given-names></name><name><surname>Biller</surname><given-names>BM</given-names></name><name><surname>de la Monte</surname><given-names>S</given-names></name><name><surname>Zervas</surname><given-names>NT</given-names></name><name><surname>Klibanski</surname><given-names>A</given-names></name><etal/></person-group><article-title>Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence.</article-title><source>J Neurosurg</source><year>1993</year><volume>78</volume><fpage>753</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.3171/jns.1993.78.5.0753</pub-id><pub-id pub-id-type="pmid">8096873</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matousek</surname><given-names>P</given-names></name><name><surname>Buzrla</surname><given-names>P</given-names></name><name><surname>Reguli</surname><given-names>S</given-names></name><name><surname>Krajca</surname><given-names>J</given-names></name><name><surname>Dvorackova</surname><given-names>J</given-names></name><name><surname>Lipina</surname><given-names>R</given-names></name></person-group><article-title>Factors that predict the growth of residual nonfunctional pituitary adenomas: correlations between relapse and cell cycle markers.</article-title><source>BioMed Res Int</source><year>2018</year><volume>2018</volume><elocation-id>1876290</elocation-id><pub-id pub-id-type="doi">10.1155/2018/1876290</pub-id><pub-id pub-id-type="pmid">30112364</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steno</surname><given-names>A</given-names></name><name><surname>Bocko</surname><given-names>J</given-names></name><name><surname>Rychly</surname><given-names>B</given-names></name><name><surname>Chorvath</surname><given-names>M</given-names></name><name><surname>Celec</surname><given-names>P</given-names></name><name><surname>Fabian</surname><given-names>M</given-names></name><etal/></person-group><article-title>Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth.</article-title><source>Acta Neurochir (Wien)</source><year>2014</year><volume>156</volume><fpage>451</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1007/s00701-014-1993-0</pub-id><pub-id pub-id-type="pmid">24452592</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trouillas</surname><given-names>J</given-names></name><name><surname>Roy</surname><given-names>P</given-names></name><name><surname>Sturm</surname><given-names>N</given-names></name><name><surname>Dantony</surname><given-names>E</given-names></name><name><surname>Cortet-Rudelli</surname><given-names>C</given-names></name><name><surname>Viennet</surname><given-names>G</given-names></name><etal/></person-group><article-title>A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.</article-title><source>Acta Neuropathol</source><year>2013</year><volume>126</volume><fpage>123</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1084-y</pub-id><pub-id pub-id-type="pmid">23400299</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>HE</given-names></name><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Sullivan</surname><given-names>N</given-names></name><name><surname>Esiri</surname><given-names>MM</given-names></name><name><surname>Wass</surname><given-names>JA</given-names></name></person-group><article-title>Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.</article-title><source>Clin Endocrinol (Oxf)</source><year>2000</year><volume>53</volume><fpage>337</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2265.2000.01088.x</pub-id><pub-id pub-id-type="pmid">10971451</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raverot</surname><given-names>G</given-names></name><name><surname>Burman</surname><given-names>P</given-names></name><name><surname>McCormack</surname><given-names>A</given-names></name><name><surname>Heaney</surname><given-names>A</given-names></name><name><surname>Petersenn</surname><given-names>S</given-names></name><name><surname>Popovic</surname><given-names>V</given-names></name><etal/></person-group><article-title>European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas.</article-title><source>Eur J Endocrinol</source><year>2018</year><volume>178</volume><fpage>G1</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1530/EJE-17-0796</pub-id><pub-id pub-id-type="pmid">29046323</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeger</surname><given-names>W</given-names></name><name><surname>Petersenn</surname><given-names>S</given-names></name><name><surname>Schofl</surname><given-names>C</given-names></name><name><surname>Knappe</surname><given-names>UJ</given-names></name><name><surname>Theodoropoulou</surname><given-names>M</given-names></name><name><surname>Buslei</surname><given-names>R</given-names></name><etal/></person-group><article-title>Emerging histopathological and genetic parameters of pituitary adenomas: clinical impact and recommendation for future WHO classification.</article-title><source>Endocr Pathol</source><year>2016</year><volume>27</volume><fpage>115</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1007/s12022-016-9419-6</pub-id><pub-id pub-id-type="pmid">26874696</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trouillas</surname><given-names>J</given-names></name><name><surname>Burman</surname><given-names>P</given-names></name><name><surname>McCormack</surname><given-names>A</given-names></name><name><surname>Petersenn</surname><given-names>S</given-names></name><name><surname>Popovic</surname><given-names>V</given-names></name><name><surname>Dekkers</surname><given-names>O</given-names></name><etal/></person-group><article-title>Aggressive pituitary tumours and carcinomas: two sides of the same coin?</article-title><source>Eur J Endocrinol</source><year>2018</year><volume>178</volume><fpage>C7</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1530/EJE-18-0250</pub-id><pub-id pub-id-type="pmid">29588294</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobsson</surname><given-names>KE</given-names></name><name><surname>Petruson</surname><given-names>B</given-names></name><name><surname>Lindblom</surname><given-names>B</given-names></name></person-group><article-title>Dynamics of visual improvement following chiasmal decompression Quantitative pre- and postoperative observations.</article-title><source>Acta Ophthalmol Scand</source><year>2002</year><volume>80</volume><fpage>512</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0420.2002.800510.x</pub-id><pub-id pub-id-type="pmid">12390163</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semela</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>EB</given-names></name><name><surname>Hedges</surname><given-names>TR</given-names></name><name><surname>Vuong</surname><given-names>L</given-names></name><name><surname>Odel</surname><given-names>JG</given-names></name><name><surname>Hood</surname><given-names>DC</given-names></name></person-group><article-title>Multifocal visual-evoked potential in unilateral compressive optic neuropathy.</article-title><source>Br J Ophthalmol</source><year>2007</year><volume>91</volume><fpage>445</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1136/bjo.2006.097980</pub-id><pub-id pub-id-type="pmid">17077118</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karppinen</surname><given-names>A</given-names></name><name><surname>Kivipelto</surname><given-names>L</given-names></name><name><surname>Vehkavaara</surname><given-names>S</given-names></name><name><surname>Ritvonen</surname><given-names>E</given-names></name><name><surname>Tikkanen</surname><given-names>E</given-names></name><name><surname>Kivisaari</surname><given-names>R</given-names></name><etal/></person-group><article-title>Transition from microscopic to endoscopic transsphenoidal surgery for nonfunctional pituitary adenomas.</article-title><source>World Neurosurg</source><year>2015</year><volume>84</volume><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2015.02.024</pub-id><pub-id pub-id-type="pmid">25731792</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>ML</given-names></name><name><surname>Zambon</surname><given-names>BK</given-names></name><name><surname>Cunha</surname><given-names>LP</given-names></name></person-group><article-title>Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.</article-title><source>Can J Ophthalmol</source><year>2010</year><volume>45</volume><fpage>404</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.3129/i09-276</pub-id><pub-id pub-id-type="pmid">20648089</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>G</given-names></name><name><surname>Pasquini</surname><given-names>E</given-names></name><name><surname>Farneti</surname><given-names>G</given-names></name><name><surname>Mazzatenta</surname><given-names>D</given-names></name><name><surname>Sciarretta</surname><given-names>V</given-names></name><name><surname>Grasso</surname><given-names>V</given-names></name><etal/></person-group><article-title>The endoscopic versus the traditional approach in pituitary surgery.</article-title><source>Neuroendocrinology</source><year>2006</year><volume>83</volume><fpage>240</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1159/000095534</pub-id><pub-id pub-id-type="pmid">17047389</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masopust</surname><given-names>V</given-names></name><name><surname>Netuka</surname><given-names>D</given-names></name><name><surname>Benes</surname><given-names>V</given-names></name><name><surname>Bradac</surname><given-names>O</given-names></name><name><surname>Marek</surname><given-names>J</given-names></name><name><surname>Hana</surname><given-names>V</given-names></name></person-group><article-title>Endonasal endoscopic pituitary adenoma resection: preservation of neurohypophyseal function.</article-title><source>J Neurol Surg A Cent Eur Neurosurg</source><year>2014</year><volume>75</volume><fpage>336</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1055/s-0034-1368687</pub-id><pub-id pub-id-type="pmid">24682928</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razak</surname><given-names>AA</given-names></name><name><surname>Horridge</surname><given-names>M</given-names></name><name><surname>Connolly</surname><given-names>DJ</given-names></name><name><surname>Warren</surname><given-names>DJ</given-names></name><name><surname>Mirza</surname><given-names>S</given-names></name><name><surname>Muraleedharan</surname><given-names>V</given-names></name><etal/></person-group><article-title>Comparison of endoscopic and microscopic trans-sphenoidal pituitary surgery: early results in a single centre.</article-title><source>Br J Neurosurg</source><year>2013</year><volume>27</volume><fpage>40</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.3109/02688697.2012.703353</pub-id><pub-id pub-id-type="pmid">22834971</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nov&#x000e1;k</surname><given-names>V</given-names></name><name><surname>Hrab&#x000e1;lek</surname><given-names>L</given-names></name><name><surname>Fry&#x00161;&#x000e1;k</surname><given-names>Z</given-names></name><name><surname>Hoza</surname><given-names>J</given-names></name><name><surname>Hu&#x0010d;ko</surname><given-names>C</given-names></name><name><surname>Krahul&#x000ed;k</surname><given-names>D</given-names></name><etal/></person-group><article-title>V&#x000fd;sledky endokrinn&#x000ed;ch funkc&#x000ed; hypof&#x000fd;zy po transsfenoid&#x000e1;ln&#x000ed;ch operac&#x000ed;ch afunk&#x0010d;n&#x000ed;ch makroadenom&#x0016f;.</article-title><source>Ces Slov Neurol Neurochir</source><year>2017</year><volume>80</volume><fpage>286</fpage><lpage>90</lpage></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomikos</surname><given-names>P</given-names></name><name><surname>Ladar</surname><given-names>C</given-names></name><name><surname>Fahlbusch</surname><given-names>R</given-names></name><name><surname>Buchfelder</surname><given-names>M</given-names></name></person-group><article-title>Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas&#x02013;a study on 721 patients.</article-title><source>Acta Neurochir (Wien)</source><year>2004</year><volume>146</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s00701-003-0174-3</pub-id><pub-id pub-id-type="pmid">14740262</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jane</surname><given-names>JA</given-names></name><name><surname>Laws</surname><given-names>ER</given-names></name></person-group><article-title>The surgical management of pituitary adenomas in a series of 3,093 patients.</article-title><source>J Am Coll Surg</source><year>2001</year><volume>193</volume><fpage>651</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S1072-7515(01)01101-2</pub-id><pub-id pub-id-type="pmid">11768682</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>AT</given-names></name><name><surname>Tucker</surname><given-names>HS</given-names></name><name><surname>Becker</surname><given-names>DP</given-names></name></person-group><article-title>Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas.</article-title><source>J Neurosurg</source><year>1984</year><volume>61</volume><fpage>577</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.3171/jns.1984.61.3.0577</pub-id><pub-id pub-id-type="pmid">6747696</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cappabianca</surname><given-names>P</given-names></name><name><surname>Cavallo</surname><given-names>LM</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>de Divitiis</surname><given-names>E</given-names></name></person-group><article-title>Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas.</article-title><source>J Neurosurg</source><year>2002</year><volume>97</volume><fpage>293</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.3171/jns.2002.97.2.0293</pub-id><pub-id pub-id-type="pmid">12186456</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majovsky</surname><given-names>M</given-names></name><name><surname>Astl</surname><given-names>J</given-names></name><name><surname>Kovar</surname><given-names>D</given-names></name><name><surname>Masopust</surname><given-names>V</given-names></name><name><surname>Benes</surname><given-names>V</given-names></name><name><surname>Netuka</surname><given-names>D</given-names></name></person-group><article-title>Olfactory function in patients after transsphenoidal surgery for pituitary adenomas-a short review.</article-title><source>Neurosurg Rev</source><year>2019</year><volume>42</volume><fpage>395</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1007/s10143-018-1034-1</pub-id><pub-id pub-id-type="pmid">30276575</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>HB</given-names></name><name><surname>Veerapen</surname><given-names>R</given-names></name></person-group><article-title>A direct transnasal approach to the sphenoid sinus. Technical note</article-title><source>J Neurosurg</source><year>1987</year><volume>66</volume><fpage>140</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.3171/jns.1987.66.1.0140</pub-id><pub-id pub-id-type="pmid">3783248</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>DY</given-names></name><name><surname>Liau</surname><given-names>WR</given-names></name></person-group><article-title>Comparison of endonasal endoscopic surgery and sublabial microsurgery for prolactinomas.</article-title><source>Surg Neurol</source><year>2002</year><volume>58</volume><fpage>371</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/S0090-3019(02)00892-3</pub-id><pub-id pub-id-type="pmid">12517610</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Same&#x00161;</surname><given-names>M</given-names></name><name><surname>Vachata</surname><given-names>P</given-names></name><name><surname>Saur</surname><given-names>K</given-names></name><name><surname>Bud&#x000ed;kov&#x000e1;</surname><given-names>M</given-names></name></person-group><article-title>P&#x00159;&#x000ed;m&#x000fd; transnaz&#x000e1;ln&#x000ed; miniinvazivn&#x000ed; p&#x00159;&#x000ed;stup pro mikrochirurgickou resekci adenom&#x0016f; hypof&#x000fd;zy.</article-title><source>Cesk Slov Neurol.</source><year>2005</year><volume>2006</volume><fpage>68</fpage></element-citation></ref><ref id="R67"><label>67</label><mixed-citation publication-type="book">N&#x000e1;hlovsk&#x000fd; J, &#x0010c;es&#x000e1;k T, L&#x000e1;tr I, &#x0010c;&#x000e1;p J, &#x0017d;i&#x0017e;ka J, Krajina A. Komplikace transsfenoid&#x000e1;ln&#x000ed;ch operac&#x000ed; u na&#x00161;ich nemocn&#x000fd;ch-p&#x00159;&#x000ed;&#x0010d;iny, &#x00159;e&#x00161;en&#x000ed;. Cesk Slov Neurol. (2004): 67.</mixed-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laws</surname><given-names>ER</given-names></name></person-group><article-title>Vascular complications of transsphenoidal surgery.</article-title><source>Pituitary</source><year>1999</year><volume>2</volume><fpage>163</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1023/A:1009951917649</pub-id><pub-id pub-id-type="pmid">11081167</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavallo</surname><given-names>LM</given-names></name><name><surname>Briganti</surname><given-names>F</given-names></name><name><surname>Cappabianca</surname><given-names>P</given-names></name><name><surname>Maiuri</surname><given-names>F</given-names></name><name><surname>Valente</surname><given-names>V</given-names></name><name><surname>Tortora</surname><given-names>F</given-names></name><etal/></person-group><article-title>Hemorrhagic vascular complications of endoscopic transsphenoidal surgery.</article-title><source>Minim Invasive Neurosurg</source><year>2004</year><volume>47</volume><fpage>145</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1055/s-2004-818489</pub-id><pub-id pub-id-type="pmid">15343429</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raymond</surname><given-names>J</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Czepko</surname><given-names>R</given-names></name><name><surname>Roy</surname><given-names>D</given-names></name></person-group><article-title>Arterial injuries in transsphenoidal surgery for pituitary adenoma; the role of angiography and endovascular treatment.</article-title><source>AJNR Am J Neuroradiol</source><year>1997</year><volume>18</volume><fpage>655</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">9127026</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakai</surname><given-names>S</given-names></name><name><surname>Fukushima</surname><given-names>T</given-names></name><name><surname>Teramoto</surname><given-names>A</given-names></name><name><surname>Sano</surname><given-names>K</given-names></name></person-group><article-title>Pituitary apoplexy: its incidence and clinical significance.</article-title><source>J Neurosurg</source><year>1981</year><volume>55</volume><fpage>187</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.3171/jns.1981.55.2.0187</pub-id><pub-id pub-id-type="pmid">7252541</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>SM</given-names></name><name><surname>Rigla</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>A</given-names></name><name><surname>Oliver</surname><given-names>B</given-names></name><name><surname>Bartumeus</surname><given-names>F</given-names></name></person-group><article-title>Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas.</article-title><source>J Clin Endocrinol Metab</source><year>1999</year><volume>84</volume><fpage>3696</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1210/jcem.84.10.6019</pub-id><pub-id pub-id-type="pmid">10523016</pub-id></element-citation></ref></ref-list></back></article>